Simplified Chinese

English

Home page

Good News | Our company’s Yang Chaohui has been awarded the 2021 Capital Labor Medal.

Release date:

2021-04-26

Author:

Source:

Abstract

On April 25, the Beijing Municipal Federation of Trade Unions announced the results of the 2021 Capital Labor Award, Capital Labor Medal, and Beijing Workers’ Vanguard titles. Yang Chaohui, Director of Vaccine Department Four at our company, was awarded the Capital Labor Medal. With a long-standing commitment to vaccine research and development and industrialization, Mr. Yang possesses strong technical expertise and extensive R&D experience, consistently pursuing innovation and leading his team in developing novel vaccines. He has previously spearheaded the development of the 13-valent pneumococcal conjugate vaccine, as well as the typhoid A conjugate vaccine and the typhoid B conjugate vaccine. Currently, he oversees the production of the 23-valent pneumococcal polysaccharide vaccine and the pilot production of the 13-valent pneumococcal conjugate vaccine at our company. Among these, 1…

4 month 25 On [date], the Beijing Municipal Federation of Trade Unions announced… 2021 Results of the selection for the Capital Labor Award, the Capital Labor Medal, and the Beijing Municipal Workers’ Vanguard Title. Yang Chaohui, Director of Vaccine Department No. 4 at our company, has been awarded the Capital Labor Medal.

Yang Chaohui has long been engaged in vaccine research and development and industrialization, possessing strong technical expertise and extensive R&D experience. Committed to innovation, he has led his team in developing next-generation vaccines. He has previously served as the principal investigator for… 13 Research and development of the pneumococcal conjugate vaccine, the paratyphoid A conjugate vaccine, and the paratyphoid B conjugate vaccine. Currently, I am responsible at our company… 23 Production of pneumococcal polysaccharide vaccine and 13 The pilot production of the pneumococcal conjugate vaccine. Among them, 13 The pneumococcal conjugate vaccine is a blockbuster product among the world’s new-generation vaccines and has been designated as a major special project by the National Health and Family Planning Commission. 2016 Post-year subsidies and 2017 Supported by the National Major Science and Technology Project for the Development of Major New Drugs, this vaccine technology represents a pioneering, cutting-edge innovation in China, serving as a viable alternative to imported products and demonstrating significant originality. The project boasts fully independent intellectual property rights and has secured multiple patent protections, thereby filling a critical domestic gap. 13 The pneumococcal conjugate vaccine is precisely manufactured with a planned production capacity of 3000 Ten million doses have been produced, addressing an urgent market need. This has broken the current passive reliance on imported vaccines, providing high-quality, affordable domestically produced vaccines to the public and enhancing the overall competitiveness of China’s vaccine industry.

It is reported that, 2021 This year, the selection and commendation work for the Capital Labor Awards, medals, and the Beijing Municipal Workers’ Vanguard Titles has begun. 3 Launched in mid-month, the process involved grassroots units convening workers’ congresses, public posting at the respective units, soliciting opinions from relevant functional departments, review by the leading group office, and district- and city-level public announcements. Ultimately, a total of Capital Labor Medals were awarded. 58 One, the Capital Labor Medal 299 Name: Beijing Municipal Workers’ Vanguard Unit 118 The Capital Labor Medal is an award established by the Beijing Municipal Federation of Trade Unions to recognize outstanding individuals who have demonstrated persistent dedication, selfless service, a spirit of reform, and pioneering innovation in their ordinary yet demanding roles. This time, Yang Chaohui of our company has been honored with this prestigious award, which has greatly inspired and encouraged all employees to actively engage in vaccine research and production. The company will also continue to… We will vigorously promote the spirit of model workers, the spirit of labor, and the spirit of craftsmanship, demonstrating a strong sense of ownership and mission. Grounded in our respective duties, we will cherish our posts, dedicate ourselves to our work, dare to innovate, and be willing to make selfless contributions, thereby making new and even greater contributions to the sustained, healthy development of the capital’s economy and society and to the realization of the Chinese Dream of national rejuvenation.

Keywords:

(Reprinted) Shenzhen Special Economic Zone Daily: Racing Against Time — The Story Behind the Development of Shenzhen Kangtai Biological’s COVID‑19 Vaccine

Zheng Haifa, General Manager of the company, was invited to attend and address the videoconference on work related to opening up the entire biopharmaceutical industry chain under the “Two Zones” initiative.

Recommended Reading

Batch Release Status of the Company’s Products in 2026

The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.

Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.

Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09

Online Customer Service

Telephone

400 189 9806

Contact Information

Customer Service Hotline

4001899806

Phone number

010-59613600

Official Website

http://www.biominhai.com

Company Address

No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing

WeChat Official Account

Business license

Website Development: China Enterprise Dynamics

Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.